Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |